BioRestorative Therapies, Inc. · NASDAQ:BRTX
BioRestorative Therapies — ASGCT 2019
14 slides from BioRestorative Therapies's conference presentation, April 2019
Slide 1: ASGCT 2019 – General Presentation
ASGCT 2019– General Presentation
Slide 2: Disclaimer
Disclaimer STATEMENTS IN THIS INVESTMENT SUMMARY (“SUMMARY”), INCLUDING THE INFORMATION SET FORTH AS TO THE FUTURE FINANCIAL OR OPERATING PERFORMANCE OF BIORESTORATIVE THERAPIES, INC. (THE “COMPANY” OR “BRT”), THAT ARE NOT CURRENT OR HISTORICAL FACTUAL STATEMENTS MAY CONSTITUTE “FORWARD LOOKING” INF
Slide 3: Mass of BAT is Inversely Correlated with Obesity and Unhealthy Metabolism
Mass of BAT is Inversely Correlated with Obesity and Unhealthy Metabolism • Obesity is a worldwide epidemic • In the U.S., 37% of adults and 16.9% of children and adolescents are obese • Obesity is a risk factor for insulin- resistance, metabolic syndrome, and cardiovascular disease • In 2012, the t
Slide 4: Brown Adipose Tissue – Novel Therapeutic to Treat Obesity and Related Metabolic Disorders
Brown Adipose Tissue – Novel Therapeutic to Treat Obesity and Related Metabolic Disorders BAT is a specialized adipose tissue • High metabolic activity • Able to dissipate energy, fatty acids, glucose to produce heat • Present in adult humans in small quantities BAT WAT 4
Slide 5: Pre-clinical studies demonstrate that BAT transplants have therapeutic benefits
Pre-clinical studies demonstrate that BAT transplants have therapeutic benefits 5
Slide 6: ThermoStem® - development of a bioengineered human BAT construct
ThermoStem® - development of a bioengineered human BAT construct • BRT has procured a large collection of human brown and white Generation 1 adipose tissues and cellular library BADSC/Scaffold • Isolated and characterized a novel allogeneic brown adipose stem cell population • Generation 1: BADSC/Sc
Slide 7: Generation 1 - Tissue procurement/cell isolation
Generation 1-Tissue procurement/cell isolation A B D F C E Fig. 1.(A) Patient demographics. Abbreviations: HDL, high-density lipoprotein; HbA1c. Glycosylated hemoglobin; BMI, body mass index; TG, triacylglycerol. Data are represented as means ± s.d. (B) Biopsy of human mediastinal adipose depot from
Slide 8: Generation 1 - Cell characterization
Generation 1-Cell characterization A B C F D G E H Tubulin 1 2 ~53 kDa UCP1 1 2 ~33 kDa Fig. 2. (A) Gene expression profile comparing undifferentiated brown adipose derived stem cells to undifferentiated white adipose derived stem cells derived from subcutaneous adipose tissue. Genes in red are asso
Slide 9: Generation 1 - Scaffold delivery
Generation 1-Scaffold delivery A B C 100 μm 100 μm 100 μm D E F G 500 μm 500 μm 500 μm 500 μm H I J K L * 200 μm 200 μm 200 um 50 μm Fig.4. In vitro culture of BADSCs. Representative bright field images of differentiated cells (A) prior to passaging and post-passaging and centrifugation (B) adherent
Slide 10: Generation 1 - Metabolic function
Generation 1-Metabolic function A B Fig. 3. (A) Functional mitochondrial respiration assay of brown adipose derived stem cells differentiated into brown adipocytes at 7, 14 and 21 days post differentiation. (B) Fatty acid uptake of brown fat differentiated brown adipose derived stem cells at 7, 14 a
Slide 11: Generation 2 - UCP-1 Expression
Normalized Expression H 0 1 2 0.5 1.5 2.5 um an B B A Gene/TBP Expression Pr AT relative to StemPro e- Di ff. G 0 1000 2000 3000 4000 5000 Po en St 1 ND em st Pr -D o i ff .G en 1 Ge Pr n1 e- Di ff. UCP1 Ge G n2 Po en UCP1 st 2 ND -D i ff 0 1 2 3 4 .G St en em Pr 2 o Su bQ Ge W n1 A T ND Vi FABP4 Ge
Slide 12: Generation 2 - Delivery Device Loading/Human BAT Construct
Generation 2-Delivery Device Loading/Human BAT Construct HE BF DAPI/Perilipin/UCP1 A GM DIFF-1 DIFF-2 D0 D1 D2 D5 D26 BAGs Device Adipocyte differentiation induction - RNA isolation Formation Loading - Histology / Immunostaining B D E DAPI Perilipin UCP1 FABP4 ADIPSIN PPARg CEBPa LEPTIN 2000 50 16 1
Slide 13: Next Steps
Next Steps • Small animal model using generation 2 device. • Explore other delivery systems • Study secretome of BADSC • Explore use for other indications 13
Slide 14: Thank You
biorestorat\|ve therapies THANK YOU